Targeting heat shock proteins 90 and 70: a promising remedy for both autoimmune bullous diseases and covid-19

HIGHLIGHTS

• who: Michael Kasperkiewicz from the University of New South Wales, Australia have published the research work: Targeting heat shock proteins 90 and 70: A promising remedy for both autoimmune bullous diseases and COVID-19, in the Journal: (JOURNAL)
• what: Hsps90/70 are involved in AIBDs and COVID-19 in many different ways and, thus, can be important therapeutic targets for both conditions, an ideal scenario during this pandemic (Figure 1).
• future: Exploration of the net effects of especially clinically available Hsp90 blockers in basic studies and clinical trials is needed.

SUMMARY . . .

 

If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.